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Myogenic effects enhance norepinephrine constriction: Inhibition
by nitric oxide and felodipine. Myogenic, pressure-induced vaso-
constriction may amplify the effects of circulating vasoconstric-
tors. Through intravital microscopy in cremaster arterioles (31 to
115 mm diameter), the relative contribution of myogenic re-
sponses (MR) to norepinephrine (NE)-induced constriction and
the inhibitor potency of nitric oxide (NO) or a Ca21 entry blocker
(CEB), felodipine (F), were examined. In 24 anesthetized ham-
sters, a vessel occluder was placed around the aorta to control
cremaster vessel inflow pressure (IP). NE infusion increased
blood pressure (by 50 6 2 mm Hg) and induced significant
constriction (24% 6 9%) in small arterioles (, 65 mm) only. The
constriction, which was not altered by adrenergic blockade, was
dependent on the actual IP and was abolished when the IP
increase was blocked. NO synthase (NOS) blockade unmasked a
significant MR in large arterioles. F inhibited the MR predomi-
nantly in large vessels. In isolated microvessels, F completely
blocked the pressure-induced Ca21 increase and MR. We con-
clude that circulating NE constricts muscle arterioles mainly by a
myogenic mechanism. NO effectively opposes MR in larger
arterioles, thus restricting MR and vasoconstrictor reinforcement
to a small section of the vasculature being tightly controlled by
metabolic signals. MR, which otherwise would impair adjustment
of peripheral resistance, is reduced by CEB predominantly in
larger arterioles, similar to NO.
Vascular smooth muscle responds to changes in trans-
mural pressure by appropriate changes of tone, thus coun-
teracting the pressure effects on smooth muscle length or
vessel wall tension. This myogenic response, well known as
the Bayliss effect, contributes greatly to the autoregulation
of blood flow and capillary pressure. Autoregulation is
considered to be especially important in the renal circula-
tion but can be observed also in the vasculature of other
organs. Apart from its physiological role, the Bayliss effect
is potentially important under pathophysiological condi-
tions, especially hypertension. Any increase in pressure
may lead to additional vasoconstriction, thereby further
increasing peripheral vascular resistance. Experimental ev-
idence indicates that part of the peripheral vasoconstriction
in response to infusions of vasoconstrictors must be attrib-
uted to indirect effects of the pressure increase [1–3]. The
potential positive feedback mechanism inherently present
in myogenic vasoconstriction requires control through op-
posing mechanisms. The endothelial vasodilator nitric ox-
ide (NO) can exert such a control function. We and others
have demonstrated before in isolated microvessels that
endothelial-derived NO can oppose pressure-induced con-
striction [4, 5]. In fact, pressure increases are accompanied
by higher endothelial wall shear stress [6, 7], which in turn
stimulates NO release. This role of NO might be especially
important in skeletal muscle because, due to its mass, this
tissue contributes considerably to the peripheral resistance.
Through intravital microscopy, we investigated whether
infusion of norepinephrine (NE) does in fact induce a
significant myogenic response in vivo and whether NO
counterbalances this effect. Furthermore, we studied
whether NO could be therapeutically substituted by a Ca21
entry blocker (CEB). Although stretch-dependent opening
of unspecific cation channels is the primary event in
myogenic constriction [8], Ca21 influx due to the secondary
depolarization could be counteracted by CEB. However, it
is not clear if and to what extent CEB can really inhibit
myogenic constrictions of microvessels, as other mecha-
nisms such as activation of protein kinase C seem to
contribute to the response [9].
METHODS
Preparation
The abdominal aorta of anesthetized hamsters was ex-
posed distal to the renal arteries, and a pneumatic occluder
(Jones) was placed around it. Carotid and femoral artery
pressures were recorded continuously. The right cremaster
muscle was prepared for intravital microscopy as described
previously [10]. Arteriolar inner diameters were examined
by video microscopy (Metallux, Leitz, Wetzlar, Germany).
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Experimental protocol
In each animal, arteriolar reactivity was tested by con-
secutive local superfusions (1 to 3 minutes) of the NO-
donor sodium nitroprusside (SNP, 1 mM) or acetylcholine
(ACh, 10 mM). Thereafter, diameter recordings were ob-
tained before and during the intravenous infusion of NE
(0.5 nmol/minute) for 8 to 10 minutes while allowing or
preventing the NE-induced pressure increases in the cre-
master circulation by the occluder. The protocol was there-
after repeated after local treatment with adrenoreceptor
blockers [prazosin, yohimbine (0.1 mM each), and propran-
olol (1 mM)]. In the second set of experiments in different
animals, arteriolar diameter changes during stepwise (20
mm Hg) increases in inflow pressure from 60 to 120 mm Hg
(achieved by stepwise deflation of the occluder) were
measured during continuous infusion of NE. The same
arterioles were then investigated after local cremaster
treatment with the NOS inhibitor Nv-nitro-L-arginine
(L-NNA, 30 mM, 30 minutes). In the third set of experi-
ments, arteriolar diameter responses to the same step-
wise increases of perfusion pressures were studied before
and after local application of the CEB felodipine (F) (1
mM).
Additionally, small skeletal muscle arterioles were iso-
lated from the gracilis muscle of hamsters and were can-
nulated and mounted in an organ bath on an inverted
microscope equipped for continuous measurement of the
outer vascular diameters and intracellular free [Ca21]
[Ca21]i by the Fura-2 method, as described elsewhere [11].
The transmural pressure in the nonperfused, deendotheli-
alized vessels could be elevated hydrostatically from 45 to
110 mm Hg. Pressure-induced diameter changes and
[Ca21]i were studied under control conditions as well as
after pretreatment with F (1 nM).
Drugs and statistics
For superfusion and in the organ bath, standard salt
solutions were used as described earlier [7, 11]. All drugs
were of analytical grade and obtained from Sigma (Deisen-
hofen, Germany), ICN (Meckenheim, Germany), Serva
(Heidelberg, Germany), Hoechst (Frankfurt, Germany), or
ASTRA (Wedel, Germany). Vascular tone was expressed
as a quotient of the vessel’s resting diameter divided by its
maximal diameter. Changes of the arteriolar inner diame-
ter on treatment were calculated as a percentage of the
respective control diameter. Comparisons within groups
were performed using paired t tests and those between
groups with analysis of variance. For multiple comparisons,
the probability values were corrected according to Bonfer-
roni. Differences were considered significant at a corrected
error probability of , 0.05.
RESULTS
A total of 85 arterioles with maximal luminal diameters
of 31 to 115 mm (65 6 2 mm) was studied in 24 animals. The
vessels exhibited varying degrees of spontaneous tone; that
is, the quotient of resting to maximal diameter was 0.38 to
0.96 (0.69 6 0.01). Local superfusion with SNP (1 mM) or
ACh (10 mM) dilated the arterioles by 65.8% 6 6.8% and
73.9% 6 4.6%, respectively. Superfusion with NE (0.1 mM)
induced an arteriolar constriction by 34% 6 2%; this was
virtually abolished (3% 6 1%) after local adrenergic
blockade.
Intravenous infusion of NE (0.5 nmol/min) increased the
arterial blood pressure within 50 6 3 seconds, from 75 6 2
to 125 6 2 mm Hg, which was maintained until the infusion
of NE was stopped. The small arterioles (diameter , 65
mm) constricted significantly, whereas larger arterioles (di-
ameter . 65 mm) showed no significant change in diame-
ter. Interestingly, local adrenergic blockade affected nei-
ther the NE-induced increase in blood pressure nor the
diameter changes in small or large arterioles (Fig. 1).
When, however, the increase in inflow pressure was
Fig. 1. Effect of intravenous norepinephrine (NE) infusion on cremaster
inflow pressure (A) and diameter (B) of small (diameter < 65 mm, N 5 7)
or large arterioles (diameter 65 to 115 mm, N 5 6). Local treatment of the
cremaster tissue with adrenoceptor blockers (LAB) did not affect pressure
increases and the subsequent vasoconstriction of small arterioles. Preven-
tion of the increase of pressure by inflation of the aortic occluder (OCC)
abolished the constriction despite continuous presence of NE. Symbols
are: (M) control; (o) LAB; (f) OCC. *P , 0.05 versus resting diameter.
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blocked by partial aortic occlusion, no significant diameter
changes occurred (Fig. 1).
In another series, we increased the inflow pressure
stepwise. After systemic blood pressure had reached a
plateau of 137 6 2 mm Hg during continuous infusion of
NE, the occluder was deflated stepwise to achieve three
20-mm Hg increases in inflow pressure. These pressure
increments did not change diameter of large arterioles
significantly (Fig. 2). Small arterioles, however, constricted
upon each increase in pressure. The renewed reduction in
inflow pressure returned the diameter to control despite
continued infusion of NE (Fig. 2).
Local L-NNA decreased arteriolar diameter by 9% 6
1% (P , 0.05) and reduced ACh-induced (from 44% 6 4%
to 30% 6 2%), but not SNP-induced (27% 6 4% vs. 25%
6 5%) dilations. In contrast to control, large arterioles now
constricted significantly, whereas the constrictions of small
arterioles were not different from control (Fig. 2). After
local application of the CEB F, pressure-passive dilations
were observed in large arterioles. In contrast, small arte-
rioles did not show pressure-dependent constrictions after
F (Fig. 2).
In isolated small arteries (diameter 174 6 12 mm, N 5 7),
suddenly increasing transmural pressure from 45 to 110
mm Hg induced an initial, pressure-passive diameter in-
crease by 11.8% 6 1.2% that was followed by a secondary,
myogenic vasoconstriction of 58% (of the initial dilation)
within the next three minutes. The pressure-passive
dilation was associated with a rapid increase of [Ca21]i
by 7.6% 6 0.9%, a level maintained throughout the
period of pressure elevation. Pretreatment with F pre-
vented both the increase in [Ca21]i and the pressure-
induced constriction (Fig. 3).
DISCUSSION
The constriction of skeletal muscle arterioles on intra-
venous infusion of NE was not attenuated by adrenergic
receptor blockers, although these effectively blocked the
Fig. 2. Effect of inflow pressure (A) on diameters (B) of small or large
arterioles in untreated vessels (N 5 37; M, control) following nitric oxide
(NO) synthase inhibition by Nv-nitro-L-arginine (LNNA, N 5 37; o) or
treatment with felodipine (N 5 21; f). *P , 0.05 versus resting diameter
at 60 mm Hg.
Fig. 3. Effect of transmural pressure increase on vascular diameters (B)
and smooth muscle Ca21 (R 5 ratio F340/F380, A) of small artery
segments (isolated from hamster gracilis muscle) before (M, control) and
after treatment with felodipine (N 5 7; o). Mean values were obtained 10,
60, and 180 seconds after pressure increase from 45 to 110 mm Hg.
Control values at 45 mm Hg were diameter, 158 6 15 versus 174 6 13 mm,
and R, 1.08 6 0.2 versus 0.84 6 0.2 (untreated versus felodipine).
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constrictor response to locally applied NE. Conversely,
prevention of the pressure increase in the cremaster
circulation completely prevented the constriction, and a
renewed increase restored it. This occurred at presum-
ably identical NE plasma concentrations and with virtu-
ally the same increases in local pressure in the upper half
of the body. Thus, it is unlikely that mechanisms other
than the increase in pressure are involved in the con-
striction. Similarly, other studies have shown that i.v.
infusion of phenylephrine constricts rat mesenteric ar-
teries only when the inflow pressure into this vascular
bed is allowed to increase [2]. Therefore, the observed
vasoconstriction is consistent with a pressure-induced
myogenic response of the cremaster vessels. If such a
myogenic constriction of a similar magnitude occurs in
other vascular beds, as suggested by other workers [1, 3],
this constriction should amplify considerably the direct
effect of a circulating vasoconstrictor on peripheral
vascular resistance. This is not to say that myogenic
constriction is the sole mechanism and action of vaso-
constrictors in the periphery. To induce myogenic con-
strictions, an initial increase in pressure must occur. This
may be elicited by a NE-induced increase in cardiac
output and/or by direct pharmacological constriction in
some organs other than skeletal muscle.
The myogenic constriction occurs predominantly in
small arterioles; large arterioles responded only weakly.
This low-pressure responsiveness of large skeletal mus-
cle arterioles is an NO-dependent phenomenon because,
after inhibition of NOS, the myogenic constriction was
extended to large arterioles. This role of NO might be
pivotal for the control of peripheral resistance during
pressure increases, as large arterioles are less well con-
trolled by metabolic signals. This is partially due to the
different distribution of a-receptor subtypes along ves-
sels of different generations [12, 13]. In the presence of
NO, real myogenic reactivity is therefore found only in a
small section of the vasculature. Conversely, any condi-
tion that impairs NO-dependent dilation will extend the
myogenic reactivity to the large arterioles, thereby en-
hancing the overall myogenic responsiveness of a vascu-
lar bed. This enhancement increases autoregulatory be-
havior and reduces the adaptive increase in blood flow
during reactive and active hyperemia, conditions associ-
ated with (re-)increases in blood pressure [14 –17]. One
might also speculate that an impaired NO release, and
hence a shift of myogenic responsiveness to large arte-
rioles, contributes to the elevated peripheral resistance
observed in certain hypertensive patients.
Furthermore, our observations in isolated small arter-
ies demonstrated that even these relatively large vessels
exhibit pressure-induced constriction in the absence of
the endothelium and hence NO. This myogenic vasocon-
striction is associated with a rapid and sustained increase
of [Ca21]i, which is obviously a necessary signal for the
induction of myogenic constriction as demonstrated by
its blockade by F. The potent effect of F also suggests
that the increase in [Ca21]i is due completely to the
influx of extracellular Ca21. Accordingly, F severely
attenuated myogenic pressure-induced constrictions in
vivo. Again, there was a difference between large and
small arterioles. The fact that the diameters remained
unchanged despite an increase in pressure suggests some
remaining myogenic reactivity in the latter. In contrast,
large arterioles completely lost their myogenic reactivity
under the same conditions. Thus, similar to NO, the CEB
F restricted myogenic reactivity to small arterioles. This
adds a new, interesting aspect to the antihypertensive
function of CEB that might inhibit very specifically
unspecific augmentation of the effect of circulating
vasoconstrictor hormones by preventing or attenuating
the Bayliss effect, at least in skeletal muscle vessels. This
could be particularly important in diseases with impaired
NO-dependent dilation, such as atherosclerosis and
some forms of hypertension.
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APPENDIX
Abbreviations used in this article are: ACh, acetylcholine; CEB, Ca21
entry blocker; F, felodipine; IP, inflow pressure; L-NNA, Nv-nitro-L-
arginine; MR, myogenic response; NE, norepinephrine; NO, nitric oxide;
NOS, nitric oxide synthase; SNP, sodium nitroprusside.
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